EVALUATING THE RISKS OF WITHDRAWAL SYMPTOMS AND REBOUND INSOMNIA UPON DISCONTINUATION OF DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER

被引：0
|
作者：
Leger, D. [1 ]
Fietze, I. [2 ]
Pain, S. [3 ]
Kinter, D. Seboek [3 ]
Flamion, B. [3 ]
Mignot, E. [4 ]
机构：
[1] Univ Paris 05, AP HP, Paris, France
[2] Univ Hosp, Ctr Sleep Med, Charit, Berlin, Germany
[3] Idorsia Pharmaceut Ltd, Allschwil, Switzerland
[4] Stanford Med, Ctr Narcolepsy, Palo Alto, CA USA
来源：
SLEEP MEDICINE | 2022年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [41] Daridorexant is Efficacious in Improving Sleep as Well as Daytime Functioning in Insomnia Patients
    Kinter, Dalma Seboek
    Mayleben, David
    Fietze, Ingo
    Zammit, Gary
    Bassetti, Claudio
    Leger, Damien
    Post, Anke
    Pain, Scott
    Roth, Thomas
    Mignot, Emmanuel
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 136 - 137
  • [42] Use of Daridorexant among Patients with Chronic Insomnia: A Retrospective Observational Analysis
    Williams, Scott G.
    Rodriguez-Cue, Domingo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [43] Insomnia disorder in patients with COPD
    Budhiraja, R.
    Parthasarathy, S.
    Quan, S. F.
    SLEEP, 2008, 31 : A290 - A290
  • [44] Differential sleep effects of eszopiclone treatment and discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder or generalized anxiety disorder
    Krystal, A.
    Schaefer, K.
    Rockett, C.
    Fava, M.
    Amato, D.
    Roth, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [45] Dose-response of daridorexant in insomnia disorder: An analysis of Phase 2 and 3 studies
    Luyet, Pierre-Philippe
    Mccall, William, V
    Bassetti, Claudio L. A.
    Braunstein, Guy
    Laurent, Johann
    Olivieri, Antonio
    Hedner, Jan
    SLEEP MEDICINE, 2024, 121 : 315 - 325
  • [46] Insomnia and generalized anxiety disorder:: Effects of cognitive behavior therapy for gad on insomnia symptoms
    Bélanger, L
    Morin, CA
    Langlois, F
    Ladouceur, R
    JOURNAL OF ANXIETY DISORDERS, 2004, 18 (04) : 561 - 571
  • [47] Neuropsychological and polysomnographic characteristics in sleep breathing disorder patients with insomnia symptoms
    Shin, W.
    Lee, K.
    Cha, H.
    Jang, E.
    Jung, K.
    SLEEP, 2007, 30 : A191 - A191
  • [48] Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed
    Chalet, Francois-Xavier
    Luyet, Pierre-Philippe
    Rabasa, Cristina
    Vaillant, Cedric
    Saskin, Paul
    Ahuja, Ajay
    Citrome, Leslie
    POSTGRADUATE MEDICINE, 2024, 136 (04) : 396 - 405
  • [49] Insomnia severity in patients with primary insomnia and insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Roth, Thomas
    Wilson, Phebe
    Schaefer, Kendyl
    Pfleeger, Kimberly
    Rubens, Robert
    Fava, Maurizio
    Pollack, Mark
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 85S
  • [50] Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats
    Hirase, Masahiro
    Ishida, Takayuki
    Kamei, Chiaki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 597 (1-3) : 46 - 50
12345